Similar to a heart transplant, the FDA-approved Total Artificial Heart replaces both failing heart ventricles and the four heart valves, eliminating the symptoms and source of end-stage biventricular failure. It is currently approved as a bridge to transplant for people dying from end-stage heart failure affecting both ventricles.
Read the health system news release about UI Healthcare’s artificial heart transplant.
Related Articles on Hospital Key Specialties:
Study: Cooling Therapy Effectively Treats Out-of-Hospital Cardiac Arrest
Trial Begins for Maryland Cardiologist Accused of Implanting 200 Unnecessary Stents
Triple Kidney Exchanges May Increase Kidney Transplants
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
